We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.4%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.9M |
| 2 |
AutoZone
AZO
|
+$61.2M |
| 3 |
Hershey
HSY
|
+$46.1M |
| 4 |
Intercontinental Exchange
ICE
|
+$41.2M |
| 5 |
General Motors
GM
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$104M |
| 2 |
Biogen
BIIB
|
+$89.3M |
| 3 |
Coca-Cola
KO
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$59.1M |
| 5 |
American Homes 4 Rent
AMH
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
626
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.25M | 0.01% |
180,748
+5,999
| +3% | +$32.4K |
|
627
Regenxbio
RGNX
$615M
| $1.25M | 0.01% |
+33,827
| New | +$1.26M |
|
628
Adaptive Biotechnologies
ADPT
$3.6B
| $1.24M | 0.01% |
+25,698
| New | +$937K |
|
629
Federal Realty Investment Trust
FRT
$10.9B
| $1.24M | 0.01% |
14,589
-880
| -6% | -$71.1K |
|
|
RYZ
630
Ryerson Holding Corp
RYZ
$1.61B
| $1.24M | 0.01% |
220,032
+67,655
| +44% | +$335K |
|
|
AJRD
631
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.24M | 0.01% |
+31,185
| New | +$1.3M |
|
|
SBBP
632
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.23M | 0.01% |
325,284
+128,636
| +65% | +$385K |
|
633
Park National Corp
PRK
$3.75B
| $1.23M | 0.01% |
17,440
| – | – |
|
|
ZAGG
634
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.23M | 0.01% |
390,293
+263,914
| +209% | +$829K |
|
|
RVI
635
DELISTED
Retail Value Inc. Common Shares
RVI
| $1.21M | 0.01% |
1,069,058
+159,919
| +18% | +$181K |
|
636
Protagonist Therapeutics
PTGX
$8.8B
| $1.21M | 0.01% |
68,279
-4,078
| -6% | -$51.2K |
|
637
Burlington
BURL
$23.3B
| $1.2M | 0.01% |
+6,098
| New | +$1.15M |
|
638
Exelon
EXC
$48.4B
| $1.2M | 0.01% |
46,330
-15,954
| -26% | -$424K |
|
639
Merchants Bancorp
MBIN
$2.24B
| $1.17M | 0.01% |
95,123
+1,295
| +1% | +$13.7K |
|
640
Chubb
CB
$141B
| $1.17M | 0.01% |
9,242
-5,741
| -38% | -$665K |
|
641
Kiniksa Pharmaceuticals
KNSA
$6.11B
| $1.15M | 0.01% |
45,157
-4,367
| -9% | -$91.2K |
|
642
Commercial Vehicle Group
CVGI
$152M
| $1.14M | 0.01% |
394,466
+5,659
| +1% | +$11.8K |
|
643
Puma Biotechnology
PBYI
$406M
| $1.13M | 0.01% |
108,689
+25,244
| +30% | +$261K |
|
644
Capital City Bank Group
CCBG
$904M
| $1.13M | 0.01% |
54,037
+5,392
| +11% | +$106K |
|
|
ALXN
645
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.13M | 0.01% |
+10,055
| New | +$1.07M |
|
|
CORR
646
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.13M | 0.01% |
+123,332
| New | +$1.55M |
|
|
CPRX
647
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.13M | 0.01% |
243,650
-4,766
| -2% | -$21.4K |
|
648
AeroVironment
AVAV
$7.91B
| $1.12M | 0.01% |
+14,095
| New | +$908K |
|
649
Seres Therapeutics
MCRB
$46.5M
| $1.12M | 0.01% |
11,765
+1,146
| +11% | +$101K |
|
650
Manhattan Associates
MANH
$9.95B
| $1.11M | 0.01% |
11,807
-178,691
| -94% | -$13.3M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2020 Portfolio in Review
As of Q2 2020, Jacobs Levy Equity Management held 1,206 positions worth $9.23B, up 19% from $7.78B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jacobs Levy Equity Management's Q2 2020 filing shows 212 new, 430 increased, 347 reduced and 177 closed positions. Its largest new stake was Lowe's Companies: 259,943 shares worth $35.1M. The largest sale was Mastercard, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q2 2020 buy was Lowe's Companies: 259,943 shares worth $35.1M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2020, an estimated $62.9M increase.
- Jacobs Levy Equity Management's biggest Q2 2020 reduction was Mastercard, cutting an estimated $104M.
- Jacobs Levy Equity Management fully exited Sysco in Q2 2020, selling an estimated $36.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 19% of its $9.23B portfolio in Q2 2020.
- Jacobs Levy Equity Management opened 212 new positions and closed 177 in Q2 2020.
- Jacobs Levy Equity Management's portfolio value rose 19% quarter-over-quarter to $9.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.